Skip to main content
Top
Published in: Annals of Hematology 10/2009

01-10-2009 | Original Article

Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease

Authors: W. Y. Au, W. W. M Lam, W. W. C. Chu, S. Tam, W. K. Wong, J. Lau, Y. M. Yeung, H. S. Y. Liu, R. Liang

Published in: Annals of Hematology | Issue 10/2009

Login to get access

Abstract

We performed MRI assessment in 37 adult Chinese patients with thalassemia intermedia and hemoglobin H disease. Despite abnormal ferritin and liver T2*, only 5% of patients had cardiac hemosiderosis. The two patients with reduced ejection fraction had normal cardiac T2*. Half of the cases showed pituitary and pancreatic iron loading. Subclinical endocrine abnormalities (HOMA, insulin growth factor) showed correlation with pancreatic, pituitary, and cardiac MRI values. Prospective data with serial functional and imaging monitoring is needed to verify the utility for chelation to improve cardiac and endocrine function in this group of patients.
Literature
1.
go back to reference Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B et al (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127(3):348–355 doi:10.1111/j.1365-2141.2004.05202.x PubMedCrossRef Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B et al (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127(3):348–355 doi:10.​1111/​j.​1365-2141.​2004.​05202.​x PubMedCrossRef
5.
go back to reference Au WY, Cheung WC, Chan GC, Ha SY, Khong PL, Ma ES (2003) Risk factors for hyperbilirubinemia and gallstones in Chinese patients with b thalassemia syndrome. Haematologica 88(2):220–222PubMed Au WY, Cheung WC, Chan GC, Ha SY, Khong PL, Ma ES (2003) Risk factors for hyperbilirubinemia and gallstones in Chinese patients with b thalassemia syndrome. Haematologica 88(2):220–222PubMed
6.
go back to reference Au WY, Lam WWM, Chu WWC, Yuen HL, Ling SC, Li CH et al (2008) A cross-sectional MRI assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica 93(5):784–786 doi:10.3324/haematol.12367 PubMedCrossRef Au WY, Lam WWM, Chu WWC, Yuen HL, Ling SC, Li CH et al (2008) A cross-sectional MRI assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica 93(5):784–786 doi:10.​3324/​haematol.​12367 PubMedCrossRef
8.
go back to reference Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. (2004)Thalassemia. Hematology (Am Soc Hematol Educ Program).14–34 Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. (2004)Thalassemia. Hematology (Am Soc Hematol Educ Program).14–34
9.
go back to reference Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E (2007) Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 49(3):329–332 doi:10.1002/pbc.21275 PubMedCrossRef Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E (2007) Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 49(3):329–332 doi:10.​1002/​pbc.​21275 PubMedCrossRef
10.
go back to reference Au WY, Lam W, Chu W, Tam S, Wong W, Chan H et al (2008) A pilot MRI study of organ specific hemosiderosis and functional correlation in Chinese patients with myelodysplasia and aplastic anemia with raised ferritin levels. Hematol Oncol 26:225–228PubMedCrossRef Au WY, Lam W, Chu W, Tam S, Wong W, Chan H et al (2008) A pilot MRI study of organ specific hemosiderosis and functional correlation in Chinese patients with myelodysplasia and aplastic anemia with raised ferritin levels. Hematol Oncol 26:225–228PubMedCrossRef
13.
14.
go back to reference Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C et al (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9(9):1187–1194 doi:10.1038/nm920 PubMedCrossRef Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C et al (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9(9):1187–1194 doi:10.​1038/​nm920 PubMedCrossRef
17.
go back to reference De Sanctis V, Gamberini MR, Borgatti L, Atti G, Vullo C, Bagni B (1985) Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload. Postgrad Med J 61(721):963–967PubMedCrossRef De Sanctis V, Gamberini MR, Borgatti L, Atti G, Vullo C, Bagni B (1985) Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload. Postgrad Med J 61(721):963–967PubMedCrossRef
Metadata
Title
Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease
Authors
W. Y. Au
W. W. M Lam
W. W. C. Chu
S. Tam
W. K. Wong
J. Lau
Y. M. Yeung
H. S. Y. Liu
R. Liang
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 10/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0701-2

Other articles of this Issue 10/2009

Annals of Hematology 10/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.